Dr Somani to continue as DCGI for next three months
He continues to hold the post with immediate effect from 16th August, 2022
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Generic Aadhaar launches 51 new medicines
These medicines will now be available at 80 per cent less prices
Concord Biotech files DRHP for IPO
The issue with a face value of Re 1 per equity share is a complete Offer For Sale (OFS) aggregating to 20,925,652 equity shares by…
Glenmark, Sun Pharma and two others recall products in US
As per the latest Enforcement Report by the US Food and Drug Administration (FDA), Glenmark is recalling over 6.5 lakh tubes of a…
Eight firms express interest in developing monkeypox vaccine to ICMR
No company has been awarded the tender yet, and it is currently under evaluation
CCI clears deal involving Sekhmet Pharmaventures and Optimus Drugs
Under the transaction, Sekhmet would buy a majority shareholding in Optimus Drugs
UK first to approve Omicron COVID shot with Moderna nod
The UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by Moderna as a booster for adults
Bharat Biotech completes clinical development for phase-III trials and booster doses for BBV154…
Data from both phase-III human clinical trials have been submitted for approval to National Regulatory Authorities
Agilent’s Vaya Raman-Handheld Spectrometer for Raw Material Identification
Designed to be used in a GMP-compliant warehouse, the Agilent Vaya Raman system accelerates the identification test by enabling…
FDA accepts supplemental Biologics Licence Application for Roche’s Polivy combination
The acceptance has been given for people with previously untreated diffuse large B-cell lymphoma